Mild Weather, Private Label Impact Reckitt Benckiser's OTC Division In Q1
Milder weather, retailer destocking and increased private label competition have all been cited by hygiene and health products maker Reckitt Benckiser as factors contributing to a 9% dip in its Over-The-Counter (OTC) division in the first quarter.
The division includes brands such as Nurofen and Gaviscon, as well as chest congestion brand Mucinex, the latter of which experienced share loss due to 'private label competition' in its category, the group said.
Sales in the OTC division stood at £470 million for the quarter.
Try European Supermarket Magazine PREMIUM – 30 Day FREE Trial.
A trial subscription gives unrestricted access to all premium site content, app content, weekly email content and European Supermarket Magazine digital edition for a full 30 days. Try it now!